Meet AstraZeneca, Johnson & Johnson, Eli Lily and more at the 14th Annual RNA Therapeutics Conference 2023 Read more
Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer Read more
Roche receives U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus Read more
Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy Read more
Phase 3 Trial of ICLUSIG (ponatinib) Met Primary Endpoint in Newly-Diagnosed Ph+ ALL, a Setting with No Targeted Treatments Approved in the US Read more
Horizon Therapeutics plc Announces Scientific Collaboration with Leading Research Institution to Advance Research in Autoimmunity and Inflammation Read more
Ascletis Announces IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors by China NMPA Read more
Ferring Pharmaceuticals and Gubra announce collaboration within inflammatory bowel disease (IBD) Read more